Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SK-VAV1-CNS
- Development stage
- Preclinical
- Lead developer
- SK Biopharmaceuticals
- Modality
- Small Molecules
01
Overview
SK-VAV1-CNS is a discovery-stage drug candidate being developed by SK Biopharmaceuticals for the treatment of central nervous system (CNS) disorders. The program focuses on the inhibition of Vav guanine nucleotide exchange factor 1 (VAV1), a key signaling protein primarily expressed in hematopoietic cells, including T-cells and microglia within the CNS. VAV1 plays a critical role in immune cell activation, migration, and the production of inflammatory cytokines. By targeting VAV1, the therapy aims to modulate neuroinflammatory pathways and suppress pathological immune responses that contribute to neurodegenerative and neuroinflammatory conditions, such as multiple sclerosis. The project is currently in the early discovery or preclinical phase of development.
- Other names
- VAV1 inhibitor (SK Biopharmaceuticals)
02
Targets
VAV1 (Guanine nucleotide exchange factor VAV1)
Beyond the preview
Go deeper on SK-VAV1-CNS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SK-VAV1-CNS.